Price $3.30 |
Market Cap
323.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
48.5
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-49.8K
|
FCF
-
|
|
Op. Margin
-888.20%
|
Net Margin
-
|
ROE
128.90%
|
ROI
203.20%
|
|
ROA
-76.20%
|
EPS Growth
55.90%
|
Current Ratio
12.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc (AMRX) | $4.95 | - | - | 1.47B | Strong Buy |
| IRIDEX Corporation (IRIX) | $6.50 | - | - | 83.4M | Strong Buy |
| Boston Scientific Corporation (BSX) | $39.54 | - | - | 56.22B | Strong Buy |
| Verastem Inc (VSTM) | $2.22 | - | - | 400.7M | Strong Buy |
| RCMW Group Inc (HPTYD) | $2.03 | - | - | 14.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
